Physician profile
Theodore Richards
NPI 1760892095
$8,153.80
in general payments reported to CMS, 2019-2025
37 companies · $409 in 2025
The $409 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,538 · 2020: $804 · 2021: $899 · 2022: $840 · 2023: $2,779 · 2024: $887 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,189 · Travel and Lodging: $790 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,188.61 |
| Travel and Lodging | $790.12 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,401.37 | 2023 | Indigo System |
| Abiomed | $1,171.18 | 2019-2022 | |
| Boston Scientific Corporation | $895.88 | 2019-2025 | Accolade Sr, Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $521.81 | 2019-2025 | Lifevest |
| Pfizer INC. | $503.46 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $463.48 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $443.45 | 2019-2025 | |
| Abbott Laboratories | $397.06 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $280.12 | 2019-2024 | Wainua |
| Medtronic, INC. | $272.13 | 2021-2025 | Linq II, Tyrx, Ffrangio |
| Shockwave Medical, INC | $251.34 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Boehringer Ingelheim Pharmaceuticals, INC. | $196.69 | 2021-2025 | Jardiance |
| Inari Medical, INC. | $180.47 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $158.21 | 2022-2025 | Camzyos, Eliquis |
| Actelion Pharmaceuticals US, INC. | $151.82 | 2023-2024 | Uptravi, Opsumit |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $100.27 | 2023-2024 | (Cm9) Amb Mon & Diag Und, (P84) Igt Devices Systems |
| Astellas Pharma US INC | $93.34 | 2019 | |
| Getinge USA Sales, LLC | $88.80 | 2022-2023 | Cardiohelp |
| Atricure, INC. | $77.10 | 2022 | |
| Lantheus Medical Imaging, INC. | $56.28 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $55.86 | 2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $51.44 | 2022-2023 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $50.06 | 2019 | |
| Baxter Healthcare | $31.51 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Teleflex LLC | $30.56 | 2023 | Turnpike |
| Inspire Medical Systems, INC. | $27.14 | 2025 | Inspire |
| Ge Healthcare | $22.88 | 2020 | |
| Daiichi Sankyo INC. | $20.91 | 2021 | |
| Heartflow, INC. | $20.69 | 2025 | |
| Convatec INC. | $20.15 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $20.05 | 2023 | Inpefa |
| Kiniksa Pharmaceuticals International, Plc | $19.47 | 2024 | Arcalyst |
| Akcea Therapeutics, INC. | $18.94 | 2020 | |
| Elutia, INC. | $16.86 | 2019 | |
| Novo Nordisk INC | $15.43 | 2024 | Ozempic |
| Terumo Medical Corporation | $14.76 | 2019 | |
| Medtronic Vascular, INC. | $12.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Richards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.